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Summary: Optimal conditions for determining the mitogenic activity of platelet growth factor in a homolo-
gous System (human palmar fascia fibroblasts/human platelet growth factor) were established. With the aid of
this System it was possible to test the active fraction from crude platelet extract following affinity chromato-
graphy on heparin-Sepharose, chromatofocusing and molecular sieve filtration. This fraction has an isoelectric
point of pH >9 with a molecular mass of about 12000 daltons and reacts with ß-thromboglobulin antiserum.
The addition of protease inhibitors proved essential for the Isolation of the active growth factor, in Order to
prevent proteolytic degradation to a biologically inactive substance that is immunologically identical to ß-
thromboglobulin. In addition to Stimulation of DNA synthesis, the isolated growth factor induces enhanced
synthesis of collagen and glycosaminoglycans in fibroblasts in vitro.
Zur Isolierung und Wirkung von wachstumsstimulierenden Faktoren aus menschlichen Thrombocyten
Zusammenfassung: Optimale Bedingungen zur Bestimmung der proliferationsstimulierenden Aktivität von
Thrombocytenwachstumsfaktor im homologen System (menschliche Fibroblasten aus Palmarfascie/mensch-
licher Thrombocytenwachstumsfaktor) wurden erarbeitet. Mit Hilfe des Testsystems konnte die aktive Frak-
tion aus dem Thromböcytenrohextrakt nach Affinitätschromatographie an Heparin-Sepharose, Chromatofo-
kussierung und Molekularsiebtrennung erfaßt werden. Diese einheitliche Fraktion besitzt einen isoelektri-
schen Punkt von pH >9, weist eine molekulare Masse von etwa 12000 Dalton auf und reagiert mit Antiserum
gegen ß-Thromboglobulin. Wesentlich für die Isolierung des aktiven Wachstumsfaktors erwies sich der Zu-
satz von Proteäsehemmern, um den proteolytischen Abbau zu einer biologisch inaktiven Substanz zu verhin-
dern. Diese ist mit ß-Thfomboglobulin immunologisch identisch. Neben einer Stimulation der DNA-Synthese
induziert der isolierte Wachstumsfaktor eine Steigerung der Kollagen- sowie der Glykosaminoglykansynthese
in Fibroblasten in vitro.
Introduction
The observation that serum, but not plasma, pro-
motes the growth of fibroblasts in vitro (1) led to the
discovery of various factors that stimulate cell
growth (2). The major component of mitogenic ac-
tivity in serum proved to be a factor originating from
*) Supported by the Deutsche Forschungsgemeinschaft (Sonder-
forschungsbereich 54).
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the -granulas of platelets (3,4). This factor exhibits
strong mitogenic activity on fibroblasts, smooth mus-
cle and synovial cells in culture (5). Various findings
have been reported regarding growth Stimulation of
vascular endothelial cells (6, 7).
Possible roles of the platelet growth factor in wound
healing, atherogenesis, and oncogenesis are under
discussion (5). A link to the pathogenesis of rheuma-
toid arthritis has been provided by Mac Carter,
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Hossler & Castor (8), who found that plasma from
patients with rheumatoid arthritis or lupus erythe-
matosus has higher levels of a connective-tissue
stimulating factor derived from platelets than
healthy controls (connective-tissue activating pep-
tide III). Myers & Christine (9) demonstrated elevat-
ed concentrations of this factor in the synovia of pa-
tients with inflammatory arthritic diseases. Weiss-
barth et al. (10) reported the induction of platelet
release by sera from patients with rheumatoid arthri-
tis.
It is difficult to make unambiguous Statements, be-
cause the platelet growth factors described by sever-
al authors in the literature differ in structure and
physical properties. Thus "platelet-derived growth
factor" (11,12,13) with a relative molecular mass of
27000-35000, "human platelet basic protein" (14)
with a relative molecular mass of 10000—15000,
"connective-tissue activating peptide III" (15) and
"low-affinity platelet factor 4" (16) both with a rela-
tive molecular mass of 9300 have all been described
äs platelet-derived factors with mitogenic activity.
Immunologically, there is no distinction between
platelet basic protein, connective-tissue activating
peptide III/low affinity platelet factor 4 and the so-
called packing protein of the platelets, ß.-thrombo-
globulin, which has no stimulatory activity. The ob-
jective of the work under review was to isolate the
platelet growth factor or factors with simultaneous
Separation of immunologically identical but inactive
factors, to obtain clues äs to the identity of the var-
ious factors described in the literature, and to devise
a test for proliferation Stimulation, in order to deter-
mine mitogenic activity. A further aim was to ascer-
tain the extent to which the proliferation-promoting
effect is associated with metabolic stimulating prop-
erties.
Isolation of platelet growth factor
The crude platelet extract was heated for 10 min at 100 °C. Pre-
cipitated protein was removed by centrifugation at 5000g, and
the clear supernatant was fractionated on Sephadex G 75 (column
75 x 2.5 cim, eluant: 0.05 mol/1 tris - 0.15 mol/1 NaCl, pH 7.8,
elution speed 10 ml/h) into molecular moieties greater than and
smaller than 60000 dalton. The low-mdlecular portion was app-
lied to a heparin-Sepharose column (12 x l cm). After washing
with 0.05 rriol/l tris - 0.15 mol/I NaCI, pH 7.8, the growth-stimu-
lating fraction was eluted with 0.05 mol/1 tris - 0.5 mol/I NaCl,
pH 7.8, dialysed against 0.05 mol/1 tris ^0.15 mol/1 NaCl,
pH 7.8, and again purified over heparin-Sepharose äs above.
Isoelectric focusing for Separation of platelet growth
factors
The material purified over heparin-Sepharose was fractionated by
chromatofocusing on PBE 94 (Pharmacia) polybuffer exchanger
pH 9.4 (column: 25 x l cm) with polybuffer 96 (Pharmacia)
pH 6.0 at an elution speed of 6 ml/h. For determining the mito^
genic activity of the fractipns A (pl > 9.0), B (pl 8.9-7.6) and C
(pl 7.5^6.5), these were again subjected to affinity chromatogra-
phy on heparin-Sepharose, after which the purified fractions were
used in the proliferation test.
Molecular sieve Separation of the factors
Molecular sieve Separation of the mitogenic fraction qbtained af-
ter chromatofocusing was performed on a Sephadex G 75 column
(120 X 1.2 cm, eluant: Dulbecco's phosphate buffer pH 7.0, elu-
tion speed 3.1 ml/h). Calibräted proteins from Boehringer, Mann-
heim served äs markers (cytochrome c: relative molecular mass
12500, chymotrypsin: relative molecular mass 25000, albumin
from chicken eggs: relative molecular mass 45000, ferritin: rela-
tive molecular mass 450000).
Inhibi t ion of proteolysis of platelet growth factor
A crude platelet extract obtained by repeated freezing and thaw-
ing without the addition of protease inhibitors was separated into
three portions (A, B, C). PortioruA »was incubated for 2 h at 4 °C,
portion B for 2 h at 37 °C and portion C for 2 h at 37 °C with the
addition of protease inhibitors (see above). Each sölutiön was
heated for 10 min to 100 °C and centrifuged for 60 min at 5000 g.
Following affinity chromatography of the supernatant on heparin-
Sepharose, mitogenic activity was determined in the proliferation
test.
ß- Thromboglobulin radioimmunoassay
The radioimmunoassay was performed with the IM 88 ß-throfn-
boglobulin RIA kit (Amersham/Buchler).
Materials and Methods
Crude platelet extract
Fresh donor citrate blood (100-500 ml) was centrifuged for 10
min at 100g. The supernatant was separated and centrifuged fqr
10 min at 1000g. The platelet Sediment was washed twice, each
time with a mixture consisting of 8 parts phosphate buffer (0.1
mol/1 NaCl, 2.68 mmol/1 KC1, 6 mmol/1 Na2HPO4 x 2H2O, 4
mmol/1 KH2PO4) and 2 parts citrate sölutiön (0.076 mol/1 citric
acid, 0.15 mol/1 Na-citrate) pH 6.8 and centrifuged for 10 min at
1000 g. The platelets were then suspended in 0.05 mol/l tris buf-
fer, containing 0.15 mol/1 NaCl (pH 7.8) and protease inhibitors
(0.1 mol/1 6-aminocaproic acid, 0.01 mol/1 EDTA, 5 mmol/1
benzamidine hydrochloride hydrate, 0.3 mmol/1 N-acetylcys-
teine). The cells were disrupted by means of fourfold deep-freez-
ing and thawing, and the crude platelet extract was separated from
cellular debris by centrifugation for 60min at 5000g and 4°C.
Cell count
The cell numbers were determined 40 h after factor applieation äs
described previously (18).
Proliferation test
Mitogenic activity was determined on the basis of [3H]thymidine
incorporation in human palmar fäscia fibroblasts (18). The cells
were preserved deep-frozen in the first to third subcülture and
seeded in plastic dishes for the test (2 cm2 culture surface). Cul-
ture medium: 89 parts Eagle's minimum essential medium
(MEM) with Earfs saline sölutiön, 2 mmoM glutamine, l part
vitamin concentrate (Flow Laboratories), 100 lU/ml (100 mg/1)
tpenicillin/streptomyein, and ten parts foetal calf serum (FCS). At-
mosphere: 95 parts air, 5 parts CO2 at 37 °C. After 48 h the medi-
um was sucked off, and the cell eultures were washed with 0.5 ml
of Dulbecco's phosphate buffer (PBS)', pH 7.0. In four to eight
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replicate determinations, 0.3 ml of a mixture consisting of 10 parts
of the fraction to be tested (dialysed against PBS) or PBS äs a
control, 85 parts medium and 5 parts PCS were then added to the
culture. After addition of 33 kBq [3H]thymidine (Amersham/
Buchler, D-3300 Braunschweig) in 0.2 ml of medium, the culture
was incubated for 24h, a time interval widely described for
[3H]thymidine incorporation experiments into 3T3 and glial cells
(14,15,19,20,21). Incubation was terminated by sucking off the
test medium and adding ethanol. The cells were then digested äs
described in I.e. (18). The incorporated activity was measured in a
Packard Tricarb 2660 liquid scintillation counter.
Optimization of the proliferation test
Optimization of the proliferation-stimulation test was carried out
äs follows:
1) Reduction of the portion of foetal calf serum in the test medi-
um from 5 to 3 to l part;
2) Variation of the cell density of the cultures and
3) shifting the time ät which the [3H]thymidine was added after
the test substance.
Optimal test conditions were determined äs follows: Inoculation
of cells to a density of approx. 10000 cells/cm2. After 48 h, test
sample added in MEM containing l part of foetal calf serum, and
incubation continued for 15h. Addition of [3H]thymidine and fur-
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Fig. 1. Stimulation of [3H]thymidine incorporation by heparin-
Sepharose purified platelet growth factor in dependence
on the concentration of foetal calf serum (in volume frac-
tion of foetal calf serum in the culture medium).
Incorporation in kBq per culture well (n = 8; 2 cm2 sur-
face, cell density about 40200 cells/cm2, 2.1 g ß-throm-
boglobulin immunoreactive material per ml medium), the
bars indicate the Standard deviation.
D control: buffer only
D sample »with platelet growth factor
Determination of [35S]sulphate and [3H]proline or
[3H]hydroxyprol ine incorporation in vitro
Fibroblasts from human palmar fascia of the second and third sub-
culture were seeded in 8 cm2 plastic culture dishes. After 24 h,
50 g of ascorbate per ml of medium was added for determination
of collagen synthesis. Forty eight hours after inoculation the medi-
um was sucked off and the cell colonies were washed with phos-
phate buffer (PBS), pH 7.0. To the culture was then added 1.5 ml
of test mixture (89 parts medium, l part foetal calf serum, and
either 10 parts of the fraction to be tested (dialysed against PBS)),
or of PBS to act äs a eontrol. For determination of glycosamino-
glycan synthesis sulphate-free medium had to be used. After an
incubation period of 24h, 121 kBq of the tracer substance
[3H]proline or 242 kBq of [35S)sulphate (Amersham/Buchler, D-
3300 Braunschweig) in 0.5 ml medium was added and incubated
for a further 48 h. The incorporation rates of [3H]proline and
[3H]hydroxyproline into collagen and [35S]suiphate into glycos-
aminoglycans were determined äs described in I.e. (18).
Results
A proliferation test, operating in a homölogous sys-
terh (human platelet factor/humäri palmar fascia fi-
broblasts), was developed for quantifying mitogenic
activity. The effects were studied of varying the con-
centration of foetal calf serum (fig. 1), the cell densi-
ty of the cultures (fig. 2), and the time at which the
labeled precursor [3H]thymidine was added after the
factor had begun to exert an effect on the cells
(fig. 3). In thte way, accelerated rates for [3H]thymi-
dine incorporation of up to 20 times the control
value were achieved. Replacement of foetal calf se-
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Fig. 2. Stimulation of [3H]thymidine incorporation by heparin-
Sepharose purified platelet growth factor in dependence
on the cell density of the culture. Incorporation in kBq per
culture well (n = 8; 2 cm2 surface; volume fraction of foe-
tal calf serum 0.01; 2.45 g ß-thromboglobulin immuno-
reactive material per ml medium), the bars indicate the
Standard deviation.
u control: buffer only
D sample with platelet growth factor
As shown in figure 4 this [3H]thymidine incorpora-
tion assay correlates well with the measurement of
cell growth. The [3H]thymidine incorporation assay
represents the more sensitive method. Sensitivity
was 200 ng of ß-thromboglobulin immunoreactive
material purified over heparin-Sepharose per ml of
test medium.
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Fig. 3. Stimulation of [3H]thymidine incorporation by heparin-
Sepharose purified platelet growth factor: Influence of the
time interval between factor application and addition of
the labeled precursor. Incorporation in kBq per culture
well (n = 6; 2 cm2 surface; cell density abqut 17500 cells/
cm2; volume fraction of foetal calf serum 0.01; 8 μg -
thromboglobulin immunoreactive material per ml medi-
um), the bars indicate the Standard deviation.
ffl control:\b,uffer only
D sample with platelet growth factor
With the help of the proliferation test Isolation of the
platelet growth factor was pursued. By repeated
deep-freezing and rethawing, using protease inhibi-
tors and molecular sieve filtration followed by affini-
ty chromatography on heparin-Sepharose, it was
possible to obtain a platelet fraction from fresh cit-
rate blood that had a high concentration of -throm-
boglobulin immunoreactive material. This fraction
exhibited marked mitogenic activity in the prolifera-
tion test (tab. 1). The addition of protease inhibitors
proved essential for the preservation of the mitogen-
ic activity of the preparation (fig. 5).
Tab. 1. Fractionation of crude platelet extract obtained from
2.3 · 1010 platelets (150 ml blood). * 3H-incqrporation =
Stimulation of [3H]thymidine incorporation into DNA by
human palmar fascia cells in kBq per culture well (2 cm2
surface; cell density 16800 cells/cm2; 3.4 μg platelet pro-















Fig. 4. Correlation of [3H]thymidine incorporation and cell
growth of human palmar fascia fibroblasts.
[3H]thymidine incorporation: in kBq per culture well (2
cm2 surface; volume fraction of foetal calf serum 0.01; cell
density 11000 cells/cm2).
Cell growth: Increase of cell number per cm2 culture sur-










































Fig. 5. Proteolysis of platelet growth factor: Incubation of crude
platelet extract s indicated, followed by inactivatioh at
100°C for 10 minutes and Separation of platelet growth
factor by heparin-Sepharose chromatography. Determi-
nation of factor activity by proliferation Stimulation test.
Incorporation in kBq per culture well (n = 6; 2 cm2 sur-
face; cell density 20500 cells/cm2; volume fraction of foe-
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Chromatofocusing of immunologically identical pla^
telet factors was undertaken to separate the substan-
ces on the basis of their diffefent isoelectric points.
Fractionation into 3 pl ranges A: >9 (platelet basic
protein), B: 8.9—7.6 (connective tiss e activating
peptide/low affinity platelet factor 4) and C: 7.5—
6.5 ( -thromboglobulin) yielded a fraction at pl >9
that was also immunologically identical to -throm-
boglobulin. Unlike the other fra^tions, however, it
retained mitogenic activity in toto (fig. 6). Its molec-
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Fig. 6. Fractionation of platelet factors by chromatofocusing on
Polybuffer exchanger 94 with Polybuffer 96 (Pharmacia),
pl ranges: A: pH >9.0, B: pH 8.9-7.6, C: pH 7.5-6.5
Platelet growth factor activity was determined after re-
chromatography on heparin-Separose. [3H]Thymidine in-
corporation in kBq per culture well (n = 6; 2 cm2 surface;
cell density about 30000 cells/cm2; volume fraction of
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Fig. 7. Stimulation of [3H]thymidine incorporation by fractions
obtained by Sephadex G 75 chromatography (column:
120 x 1.5 cm, eluted with Dulbecco's phosphate buffer,
3 ml per hour, V() = 38.5 ml) of platelet growth factor
pfeviously purified by chromatography on heparin-Sepha-
rose and chromatofocusing. [3H)Thymidine incorporation
in kBq per culture well (n = 6; 2 cm2 surface; cell density




ular rnass was determined to be approximately
12500 daltons. The corresponding fraction also
proved to be immunologically identical to ß-throm^
boglobulin after molecular sieve filtration (fig. 7).
The determined molecular mass agrees with that de-
scribed by Paul for platelet basic protein. No prolif-
eration Stimulation in the molecular mass ränge of
27000-35000 daltons, äs reported for platelet-de-
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Fig. 8. Effect of purified platelet growth factor on the metabolism
of cultured palmar fascia cells. Incorporation in kBq per
culture well (n = 4; 8 cm2 surface; volume fraction offoe-
tal calf serum 0.01; cell density 23100 cells/cm2 for
[35S]sulphate incorporation, 46000 cells/cm2 for [3H]pro-
line and [3H]hydroxyproline incorporation, respectively).
Labeled precursors were added 20 hours after addition of
the factor (350 ng ß-thromboglobulin immunoreactive
material per ml culture medium). Incorporation time 48
hours. The bars indicate the Standard deviation.
DU controk buffer only
D sample with platelet growth factor
The isolated growth factor exhibited mitogenic prop-
erties in the proliferation test. Thus the addition of
350 ng of platelet factor per test preparation leads to
about a seven-fold increase in DNA synthesis äs
compared to the control value. Moreover, the factor
also demonstrates an ability, although not äs pro-
nounced, to stimulate collagen and glycosaminogly-
can metabolism.
As can seeri from the results in figure 8, 350 ng of
platelet factor per test preparation induces an in-
crease in the glycosaminoglycan synthesis rate (mea-
sured on the basis of [35S]sulphate incorporation) by
a factor of 1.5, äs well äs an acceleration in collagen
synthesis (measured on the basis of [3H]proline and
[3H]hydroxyproline incorporation) by a factor of 2.5.
Discussion
Several authors have described mitogenic factors in
platelets that are released during blood coagulation
or are poured into the bloodstream from cc-granula
of the platelets in a release reaction. The methods
employed to isolate these factors from platelets part-
ly determine the definition and properties of the fac-
tors themselves.
As the results show, we were able to demonstrate a
mitogenic factor in crude platelet extracts. The fac-
tor yields positive results in the ß-thromboglobulin
J. Clin. Chem. Clin. Biochem. / Vol. 22,1984 / No. 8
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radioimmunoassay and exhibits mitogenic activity in
the proliferation test. The addition ofprotease inhib-
itors was essential for obtaining the mitogenic com-
pound. In the absence of these inhibitors, the factor
is degraded by cell or tissue proteases to ß-thrombo-
globulin, which is inactive äs a stimulator. A similar
degradation of connective tissue activating peptide
III has been discussed by Castor (22). In vivo, espe-
cially in plasma, the proteases appear to function by
limiting the effect of the platelet growth factor,
thereby counteracting any excess release of the fac-
tor.
With the aid of chroniatofocusing it was possible to
separate the growth stimulating fraction from immu-
nologically identical factors on the basis of their dif-
ferent isoelectric points (pl) — platelet basic protein
(pl: 10.0), connective tissue activating peptide/low
affinity platelet factor 4 (pl: 8.0-8.5) and ß-throm-
boglobulin (pl: 7-0). It was shown that only the frac-
tion having an isoelectric point of greater than 9 ex-
hibits mitogenic activity. The fraction containing
connective tissue activating peptide III exhibited no
activity in the proliferation test; this observation dis-
agrees with the results of Castor. The discrepancy
could be accounted for if we assume that the method
used by Castor probably did not achieve complete
Separation of platelet basic protein and connective
tissue activating peptide III. A relative molecular
mass of about 12500 was determined for the isolated
growth factor. At the same time the substance
proved to be immunologically identical to ß-throm-
boglobulin. These results agree with the data pub-
lished by Paul et al. (14) for the human platelet basic
protein.
In the relative molecular mass ränge of about 30000,
in which platelet derived growth factor (pl: 10.0)
was expected, (according to Heldin et al. (23) this
factor does not cross-react with ß-thromboglobulin
antiserum), we observed no increase in the rate of
[3H]thymidine incorporation. The reason for this
may lie in the substantially lower initial quantities of
these substance in the crude platelet extract (200
times less), äs measured by ß-thromboglobulin im-
munoreactive material. Further, inactivation of pla-
telet-derived growth factor during the chromatofoc-
using step must be considered. This, however, re-
quires further investigation.
monkey smooth muscle cells by platelet growth fac-
tor. Castor et al. (25) observed increased release of
acidic glycosaminoglycans into the culture medium
of human fibroblasts following the addition of pla-
telet factor. § f
From the above results the following picture
emerges. Human platelet basic protein with a rela-
tive molecular mass of about 12000 represents the
active growth factor from platelets. This compound
is degraded by the cleavage of oligopeptides to form
connective tissue activating peptide/low affinity pla-
telet factor 4 and theii ß-thromboglobulin, with the
immunological determinants remaining intäct.
The above described proliferation test was based not
on the 3T3 mouse cells widely cited in the literature
for determination of mitogenic activity, but rather on
a homologous System (human fibrpblasts/human
platelet factor). For improved reproducibility and in
order to avoid dedifferentiation phenomena äs far äs
possible, it is advisable tö work with only a single cell
line in the second to fourth subcultures. There seems
to be no need for addition of a 'prpgr ession factor'
(26). Obviously the calf serum used in the culture
media provides sufficient somatomedin activity to
enable the fibroblasts to answer the Stimulation by
the platelet growth factor (competence factor).
In this System the Variation coefficient (CV) is less
than 10%. Comparisons with experiments using var-
ious cell lines are not possible due to the high bio-
logical variance involved. Experiments with perman-
ent lines of human fibroblasts äs test cells are now in
progress.
In addition to the use of the test for characterizing
the mitogenic activity of fractions and factors isolat-
ed from platelets, the System also permitted the di-
rect assay of the mitogenic activity of factors re-,
leased from platelets in biological material, following
their isolation by heparin-Sepharose chromatogra-
phy. This is all the more important, äs the elevated
ß-thromboglobulin levels (plasma/synovia) reported
by Mac Carter (8) and Myers & Christine (9) in rheu-
matic diseases provide no Information on the quanti-
ty of active growth factor. The ß-thromboglobülin
radioimmunoassay represents only a very sensitive
method for detecting enhanced thrombocytic func-
tion.
Besides marked mitogenic properties, the isolaited
platelet growth factor also stimulated glycosamino-
glycan and Collagen synthesis. This coincides with
the findings of other authors. Thus Burke & ROSS
(24) described Stimulation of collagen synthesis in
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